Követés
Shreya Chappidi
Shreya Chappidi
University of Cambridge & National Cancer Institute
E-mail megerősítve itt: cam.ac.uk
Cím
Hivatkozott rá
Hivatkozott rá
Év
Who goes first? Influences of human-AI workflow on decision making in clinical imaging
R Fogliato, S Chappidi, M Lungren, P Fisher, D Wilson, M Fitzke, ...
Proceedings of the 2022 ACM Conference on Fairness, Accountability, and …, 2022
812022
Advancing human-AI complementarity: The impact of user expertise and algorithmic tuning on joint decision making
K Inkpen, S Chappidi, K Mallari, B Nushi, D Ramesh, P Michelucci, ...
ACM Transactions on Computer-Human Interaction 30 (5), 1-29, 2023
452023
Spatialized audio and hybrid video conferencing: Where should voices be positioned for people in the room and remote headset users?
J Hyrkas, AD Wilson, J Tang, H Gamper, H Sodoma, L Tankelevitch, ...
Proceedings of the 2023 CHI Conference on Human Factors in Computing Systems …, 2023
82023
Exploring serum inflammatory markers and the acute phase response in glioblastoma multiforme pre-and post-concurrent chemoradiation
S Jagasia, J Shephard, E Tasci, T Joyce, S Chappidi, TC Zgela, M Sproull, ...
Gene & Protein in Disease 3 (3), 3580, 2024
22024
Diagnosing Progression in Glioblastoma—Tackling a Neuro-Oncology Problem Using Artificial-Intelligence-Derived Volumetric Change over Time on Magnetic Resonance Imaging to …
MJ Belue, SA Harmon, S Chappidi, Y Zhuge, E Tasci, S Jagasia, T Joyce, ...
Diagnostics 14 (13), 1374, 2024
22024
MGMT ProFWise: Unlocking a New Application for Combined Feature Selection and the Rank-Based Weighting Method to Link MGMT Methylation Status to Serum Protein Expression in …
E Tasci, Y Shah, S Jagasia, Y Zhuge, J Shephard, MO Johnson, ...
International Journal of Molecular Sciences 25 (7), 4082, 2024
22024
MetaWise: combined feature selection and weighting method to link the serum metabolome to treatment response and survival in glioblastoma
E Tasci, M Popa, Y Zhuge, S Chappidi, L Zhang, TC Zgela, M Sproull, ...
International Journal of Molecular Sciences 25 (20), 10965, 2024
12024
Evaluating Serum CXCL Levels as Potential Biomarkers in Glioblastoma: Observed Alteration with Concurrent Chemoirradiation in Upfront Management
J Shephard, S Jagasia, E Tasci, T Joyce, S Chappidi, T Cooley-Zgela, ...
International Journal of Radiation Oncology, Biology, Physics 120 (2), e271, 2024
12024
Defining and capturing progression in glioma by harnessing NLP in unstructured electronic health records
S Chappidi, H Lee, S Jagasia, C Syal, G Zaki, D Junkin, N Golightly, ...
Cancer Research 84 (6_Supplement), 6199-6199, 2024
12024
Serum CD133-Associated Proteins Identified by Machine Learning Are Connected to Neural Development, Cancer Pathways, and 12-Month Survival in Glioblastoma
T Joyce, E Tasci, S Jagasia, J Shephard, S Chappidi, Y Zhuge, L Zhang, ...
Cancers 16 (15), 2740, 2024
2024
Baseline and alteration in pre vs post standard of care management serum-derived inflammatory markers are associated with radiation treatment volumes and patient outcomes in …
SV Jagasia, T Joyce, S Chappidi, E Tasci, TC Zgela, M Mackey, M Sproull, ...
Cancer Research 84 (6_Supplement), 4992-4992, 2024
2024
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–11